Identification of FLOT2 as a novel target for microRNA-34a in melanoma

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 6, 2015, Pages 993-1006

  Liu, Rui ^a   Xie, Huiqing ^a   Luo, Chengqun ^a   Chen, Zizi ^a   Zhou, Xiao ^b   Xia, Kun ^b   Chen, Xiang ^c   Zhou, Ming ^b   Cao, Peiguo ^a   Cao, Ke ^a   Zhou, Jianda ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Flotillin 2; Melanoma; Metastasis; MicroRNA 34a; Proliferation

Indexed keywords

FLOTILLINS; MEMBRANE PROTEIN; MICRORNA; MIRN34 MICRORNA, HUMAN;

CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; MELANOMA; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR TARGETED THERAPY; REAL-TIME POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84937965345     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1874-1     Document Type: Article

References (49)

1. Balch CM et al (2013) Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 20:3961–3968. doi:10.1245/s10434-013-3100-9
2. Bhatia S, Thompson JA (2012) Systemic therapy for metastatic melanoma in 2012: dawn of a new era. J Natl Compr Cancer Netw JNCCN 10:403–412
3. Bhullar RP, Bhullar A, Vanaki SS, Puranik RS, Sudhakara M, Kamat MS (2012) Primary melanoma of oral mucosa: A case report and review of literature. Dent Res J 9:353–356
4. Boyle GM et al (2011) Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 24:525–537. doi:10.1111/j.1755-148X.2011.00849.x
5. Cancer Facts and Figures (2013). American Cancer Society. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf
6. Cao K et al (2014a) SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol Res 21:271–279. doi:10.3727/096504014X13946737557031
7. Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L, Dong X (2014b) miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. J Cancer Res Clin Oncol. doi:10.1007/s00432-014-1725-0
8. Chakraborty C, George Priya Doss C, Bandyopadhyay S (2013) miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’ molecule moving as a monitor in the ‘genomic galaxy’ Curr Drug Targets 14:1110–1117
9. Chen Y, Zhu X, Zhang X, Liu B, Huang L (2010) Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Therapy J Am Soc Gene Therapy 18:1650–1656. doi:10.1038/mt.2010.136
10. Choi SE et al (2013) Elevated microRNA-34a in obesity reduces NAD + levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 12:1062–1072. doi:10.1111/acel.12135
11. Doherty SD, Prieto VG, George S, Hazarika P, Duvic M (2006) High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res 16:461–463. doi:10.1097/01.cmr.0000222592.75858.20
12. Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K, Schwarzenbach H (2013) Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem 59:1489–1496. doi:10.1373/clinchem.2013.205161
13. Garofalo M et al (2013) MiR-34a/c-Dependent PDGFR-alpha/beta downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS ONE 8:e67581. doi:10.1371/journal.pone.0067581
14. Gocze K et al (2013) Unique microRNA expression profiles in cervical cancer. Anticancer Res 33:2561–2567
15. Greenberg E et al (2011) Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS ONE 6:e18936. doi:10.1371/journal.pone.0018936
16. Hazarika P et al (2004) Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 64:7361–7369. doi:10.1158/0008-5472.can-04-0823
17. He L et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828–833. doi:10.1038/nature03552
18. He L et al (2007a) A microRNA component of the p53 tumour suppressor network. Nature 447:1130–1134. doi:10.1038/nature05939
19. He X, He L, Hannon GJ (2007b) The guardian’s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67:11099–11101. doi:10.1158/0008-5472.CAN-07-2672
20. Heinemann A et al (2012) Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res 72:460–471. doi:10.1158/0008-5472.CAN-11-1977
21. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143–159. doi:10.1002/emmm.201100209
22. Kahr HS, Mejlgaard E, Lund B (2013) Primary malignant melanoma of the vagina. Ugeskr Laeger 175:133–134
23. Kim HR, Roe JS, Lee JE, Cho EJ, Youn HD (2013) p53 regulates glucose metabolism by miR-34a. Biochem biophysical research Commun 437:225–231. doi:10.1016/j.bbrc.2013.06.043
24. Levati L et al (2011) MicroRNA-155 targets the SKI gene in human melanoma cell lines. Pigment Cell Melanoma Res 24:538–550. doi:10.1111/j.1755-148X.2011.00857.x
25. Lim LP et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769–773. doi:10.1038/nature03315
26. Lodygin D et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell cycle (Georgetown, Tex) 7:2591–2600
27. Tarasov V et al (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (Georgetown, Tex) 6:1586–1593
28. Lu C, Rak JW, Kobayashi H, Kerbel RS (1993) Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53:2708–2711
29. Lu R et al (2014) miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J Cancer Res Clin Oncol 140:387–397. doi:10.1007/s00432-013-1577-z
30. Malaga-Trillo E, Laessing U, Lang DM, Meyer A, Stuermer CA (2002) Evolution of duplicated reggie genes in zebrafish and goldfish. J Mol Evol 54:235–245. doi:10.1007/s00239-001-0005-1
31. Matsumoto S et al (2013) Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res 113:322–326. doi:10.1161/CIRCRESAHA.113.301209
32. Nemlich Y et al (2013) MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Investig 123:2703–2718. doi:10.1172/JCI62980
33. Nesca V et al (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:2203–2212. doi:10.1007/s00125-013-2993-y
34. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358–369. doi:10.1038/nrg3198
35. Rivera-Milla E, Stuermer CA, Malaga-Trillo E (2006) Ancient origin of reggie (flotillin), reggie-like, and other lipid-raft proteins: convergent evolution of the SPFH domain. Cell Mol Life Sci CMLS 63:343–357. doi:10.1007/s00018-005-5434-3
36. Saleiban A, Faxalv L, Claesson K, Jonsson JI, Osman A (2014) miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells. Pigment Cell Melanoma Res 27:431–441. doi:10.1111/pcmr.12217
37. Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R (2010) MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer J Int Cancer 126:2553–2562. doi:10.1002/ijc.24960
38. Shang JX, Zhang D, Zhang JT, Zhao JZ, Zhang Y (2013) Melanocytic neoplasms of central nervous system analysis. Zhonghua yi xue za zhi 93:34–36
39. Siegel R et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241. doi:10.3322/caac.21149
40. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. doi:10.3322/caac.21208
41. Spagnolo F, Caltabiano G, Queirolo P (2012) Uveal melanoma. Cancer Treat Rev 38:549–553. doi:10.1016/j.ctrv.2012.01.002
42. Villares GJ, Zigler M, Bar-Eli M (2011) The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis—a possible therapeutic target. Oncotarget 2:8–17
43. Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP (1999) Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 274:12702–12709
44. Xiao GH, Luo CQ, Tang GM, Zhou JD (2005) [Human endostatin gene transfected adult skin melanoma cells]. Zhong nan da xue xue bao Yi xue ban= J Central South Univ Med Sci 30:677–681
45. Xu D et al (2012) Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett 4:941–946. doi:10.3892/ol.2012.878
46. Yamazaki H et al (2012) Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med 3:793–796. doi:10.3892/etm.2012.497
47. Yan D et al (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50:1559–1565. doi:10.1167/iovs.08-2681
48. Zhao F, Zhang J, Liu YS, Li L, He YL (2011) Research advances on flotillins. Virol J 8:479. doi:10.1186/1743-422X-8-479
49. Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res 71:6561–6566. doi:10.1158/0008-5472.can-11-1432